These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 19415576)

  • 41. Liquid injectable silicone for soft tissue augmentation.
    Prather CL; Jones DH
    Dermatol Ther; 2006; 19(3):159-68. PubMed ID: 16784515
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Injectable Poly-L-Lactic Acid: Understanding Its Use in the Current Era.
    Lorenc ZP; Greene T; Gottschalk RW
    J Drugs Dermatol; 2016 Jun; 15(6):759-62. PubMed ID: 27272085
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Collagen Stimulators: Poly-L-Lactic Acid and Calcium Hydroxyl Apatite.
    Breithaupt A; Fitzgerald R
    Facial Plast Surg Clin North Am; 2015 Nov; 23(4):459-69. PubMed ID: 26505542
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chart Review Presenting Safety of Injectable PLLA Used With Alternative Reconstitution Volume for Facial Treatments.
    Palm M; Mayoral F; Rajani A; Goldman MP; Fabi S; Espinoza L; Andriopoulos B; Harper J
    J Drugs Dermatol; 2021 Jan; 20(1):118-22. PubMed ID: 33400413
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Juvéderm: a hyaluronic acid dermal filler.
    Monheit GD; Prather CL
    J Drugs Dermatol; 2007 Nov; 6(11):1091-5. PubMed ID: 18038495
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Poly-L-lactic acid facial rejuvenation: an alternative to autologous fat?
    Buckingham ED
    Facial Plast Surg Clin North Am; 2013 May; 21(2):271-84. PubMed ID: 23731588
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immediate Use After Reconstitution of a Biostimulatory Poly-L-Lactic Acid Injectable Implant.
    Baumann K; Alm J; Norberg M; Ejehorn M
    J Drugs Dermatol; 2020 Dec; 19(12):1199-1203. PubMed ID: 33346524
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expanding Treatment Options for Injectable Agents.
    Goldberg DJ; Bass LM; Fitzgerald R; Graivier MH; Lorenc ZP
    Aesthet Surg J; 2018 Apr; 38(suppl_1):S1-S7. PubMed ID: 29897519
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Semipermanent filler treatment of HIV-positive patients with facial lipoatrophy: long-term follow-up evaluating MR imaging and quality of life.
    van Rozelaar L; Kadouch JA; Duyndam DA; Nieuwkerk PT; Lutgendorff F; Karim RB
    Aesthet Surg J; 2014 Jan; 34(1):118-32. PubMed ID: 24334306
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hyaluronic acid fillers for the male patient.
    Monheit GD; Prather CL
    Dermatol Ther; 2007; 20(6):394-406. PubMed ID: 18093013
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Soft tissue augmentation: nonsurgical approaches to treatment of the mid and lower facial regions.
    Busso M
    Dermatol Nurs; 2008 Jun; 20(3):211-4, 217-9. PubMed ID: 18649706
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Calcium hydroxylapatite filler for facial rejuvenation: a histologic and immunohistochemical analysis.
    Berlin AL; Hussain M; Goldberg DJ
    Dermatol Surg; 2008 Jun; 34 Suppl 1():S64-7. PubMed ID: 18547184
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fillers and neocollagenesis.
    Carruthers JD; Carruthers JA; Humphrey S
    Dermatol Surg; 2014 Dec; 40 Suppl 12():S134-6. PubMed ID: 25417563
    [No Abstract]   [Full Text] [Related]  

  • 54. Cosmetic use of poly-L-lactic acid: my technique for success and minimizing complications.
    Goldman MP
    Dermatol Surg; 2011 May; 37(5):688-93. PubMed ID: 21457395
    [No Abstract]   [Full Text] [Related]  

  • 55. Biocompatibility of microparticles into soft tissue fillers.
    Laeschke K
    Semin Cutan Med Surg; 2004 Dec; 23(4):214-7. PubMed ID: 15745227
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Soft tissue fillers for management of the aging perioral complex.
    Sclafani AP
    Facial Plast Surg; 2005 Feb; 21(1):74-8. PubMed ID: 15988659
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A novel approach to structural facial volume replacement.
    Sadick NS; Manhas-Bhutani S; Krueger N
    Aesthetic Plast Surg; 2013 Apr; 37(2):266-76. PubMed ID: 23358580
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative physical properties of hyaluronic acid dermal fillers.
    Kablik J; Monheit GD; Yu L; Chang G; Gershkovich J
    Dermatol Surg; 2009 Feb; 35 Suppl 1():302-12. PubMed ID: 19207319
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Human histology and persistence of various injectable filler substances for soft tissue augmentation.
    Lemperle G; Morhenn V; Charrier U
    Aesthetic Plast Surg; 2003; 27(5):354-66; discussion 367. PubMed ID: 14648064
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Physiochemical Characteristics of Poly-L-Lactic Acid (PLLA).
    Fitzgerald R; Bass LM; Goldberg DJ; Graivier MH; Lorenc ZP
    Aesthet Surg J; 2018 Apr; 38(suppl_1):S13-S17. PubMed ID: 29897517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.